Clinical relevance of the substitution of different brands of sustained-release theophylline
- 1 April 1988
- journal article
- research article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 81 (4) , 664-673
- https://doi.org/10.1016/0091-6749(88)91036-6
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Inconsistent absorption from a susstained-release theophylline preparation during continuous therapy in asthmatic childrenThe Journal of Pediatrics, 1985
- Slow-Release Theophylline Rationale and Basis for Product SelectionNew England Journal of Medicine, 1983
- Theophylline A “State of the Art” ReviewPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1983
- Sustained-release theophylline: A significant advance in the treatment of childhood asthmaThe Journal of Pediatrics, 1982
- Relationship of formulation and dosing interval to fluctuation of serum theophylline concentration in children with chronic asthmaThe Journal of Pediatrics, 1981
- Intrasubject variation in sustained-release theophylline absorptionJournal of Allergy and Clinical Immunology, 1981
- The Relation of Product Formulation to Absorption of Oral TheophyllineNew England Journal of Medicine, 1978
- Clinical experience with theophylline. Relarionships between dosage, serum concentration, and toxicityJAMA, 1976
- Evaluation of oral bronchodilator therapy in asthmatic childrenThe Journal of Pediatrics, 1974
- Pharmacokinetics of theophylline; Application to adjustment of the clinical dose of aminophyllineClinical Pharmacology & Therapeutics, 1972